# Taima TB: 3HP Study

> **NCT02689089** · PHASE4 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 182 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** 3HP

## Key facts

- **NCT ID:** NCT02689089
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-28
- **Primary completion:** 2019-08-15
- **Final completion:** 2019-08-15
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2020-03-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02689089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02689089, "Taima TB: 3HP Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02689089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*